Found: 13
Select item for more details and to access through your institution.
Expression and function of the high affinity αIibβ3 integrin in murine melanoma cells.
- Published in:
- Clinical & Experimental Metastasis, 1998, v. 16, n. 5, p. 437, doi. 10.1023/A:1006533508560
- By:
- Publication type:
- Article
Parallel expression of αIIbβ3 and αvβ3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype.
- Published in:
- International Journal of Cancer, 2005, v. 116, n. 1, p. 27, doi. 10.1002/ijc.20991
- By:
- Publication type:
- Article
CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice.
- Published in:
- International Journal of Cancer, 2004, v. 111, n. 4, p. 592, doi. 10.1002/ijc.20270
- By:
- Publication type:
- Article
CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo.
- Published in:
- International Journal of Cancer, 2004, v. 110, n. 3, p. 326, doi. 10.1002/ijc.20116
- By:
- Publication type:
- Article
Role for β3 integrins in human melanoma growth and survival.
- Published in:
- International Journal of Cancer, 2002, v. 101, n. 2, p. 156, doi. 10.1002/ijc.10521
- By:
- Publication type:
- Article
Ectopic expression of platelet integrin αIIbβ3 in tumor cells from various species and histological origin.
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 4, p. 642, doi. 10.1002/(SICI)1097-0215(19970807)72:4<642::AID-IJC16>3.0.CO;2-D
- By:
- Publication type:
- Article
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma ( NPI-0052-107): final study results.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 1, p. 41, doi. 10.1111/bjh.14987
- By:
- Publication type:
- Article
Marizomib for central nervous system-multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 221, doi. 10.1111/bjh.14498
- By:
- Publication type:
- Article
Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 711, doi. 10.1111/bjh.14113
- By:
- Publication type:
- Article
Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD® immunomodulatory drug pomalidomide.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 798, doi. 10.1111/bjh.13780
- By:
- Publication type:
- Article
Role of αIIbβ3 integrin in prostate cancer metastasis.
- Published in:
- Prostate, 1998, v. 35, n. 3, p. 185, doi. 10.1002/(SICI)1097-0045(19980515)35:3<185::AID-PROS4>3.0.CO;2-G
- By:
- Publication type:
- Article
Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications.
- Published in:
- Pathology & Oncology Research, 2000, v. 6, n. 3, p. 163, doi. 10.1007/BF03032368
- By:
- Publication type:
- Article
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 6, p. 840, doi. 10.1093/neuonc/nov299
- By:
- Publication type:
- Article